FDA 483 & Warning Letter Response

FDA 483 & Warning Letter Response

Receiving an FDA Form 483 or Warning Letter is one of the most time-sensitive and consequential events a medical device company can face. We provide experienced, strategic support to help you craft responses that are credible, thorough, and demonstrate genuine commitment to sustainable compliance — giving you the best possible outcome with FDA.

What We Offer

• Rapid Response Planning — Time is critical. We engage quickly to assess the observations or violations cited, help you understand FDA's concerns in context, and develop a structured response strategy before your deadline.
• 483 Response Development — We prepare well-organized, technically sound responses to FDA Form 483 observations that acknowledge the findings, provide immediate corrective actions taken, and commit to systemic long-term remediation — reducing the likelihood of escalation to a Warning Letter.
• Warning Letter Response Development — We draft comprehensive Warning Letter responses that address each cited violation with specificity, outline your corrective action plan with realistic timelines, and communicate a clear path to full compliance in the formal tone FDA expects.
• Root Cause Analysis Support — We lead the investigation behind each observation to identify true root causes, ensuring your response reflects genuine understanding of what went wrong — not just surface-level fixes that FDA will see through.
• Corrective Action Planning — We develop detailed, prioritized corrective action plans that map directly to each observation, with defined owners, milestones, and effectiveness verification criteria.
• Quality System Gap Remediation — Beyond the response itself, we help you close the underlying quality system gaps that led to the findings — so your commitments to FDA are backed by real, verifiable change.
• Mock Inspection & Inspection Readiness — Following a 483 or Warning Letter, we help prepare your team for the inevitable re-inspection — conducting mock audits, coaching personnel, and ensuring your remediated systems are ready for FDA scrutiny.
• Ongoing FDA Communication Support — We assist with follow-up correspondence, status updates, and any additional information requests from FDA throughout the remediation process.

Why It Matters

FDA expects 483 responses within 15 business days, and Warning Letter responses within 15 working days — leaving little time for a poorly coordinated or inadequate reply. A weak response can accelerate escalation, trigger import alerts, result in product seizure, or lead to a Consent Decree. A strong, well-documented response signals to FDA that your organization takes compliance seriously and has the capability to self-correct — which is exactly what regulators want to see.

Who We Serve

We support medical device manufacturers of all sizes — from startups facing their first inspection to established companies managing complex, multi-site Warning Letters. Whether you need end-to-end response management or expert review of a draft already in progress, we are ready to help.